Andrea McCoy, NP
Gerontology · Terre Haute, INNPI 1053032482
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.7% of the total across 242 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 17.5% — the pattern of someone who eats at a lot of different presentations. Among gerontology clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 242 payments — averaging $23.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$991
- Lilly USA, LLC$696
- Corcept Therapeutics$622
- Amgen$463
- Xeris Pharmaceuticals, Inc.$386
- Novo Nordisk$277
- plus $2K from 24 others
What the payments were for
- Travel & lodging$2815%
- Food & beverage$5,36095%
- Education$200%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 23 | $991 |
| Lilly USA, LLC | 37 | $696 |
| Corcept Therapeutics | 34 | $622 |
| Amgen(2 entities) | 13 | $463 |
| Xeris Pharmaceuticals, Inc. | 20 | $386 |
| Novo Nordisk | 17 | $277 |
| AstraZeneca | 7 | $262 |
| Novartis | 11 | $243 |
| Bayer | 13 | $230 |
| Radius Health, Inc. | 9 | $215 |
| Dexcom, Inc. | 2 | $168 |
| Insulet Corporation | 8 | $153 |
| AbbVie | 7 | $118 |
| Madrigal Pharmaceuticals | 1 | $95 |
| BETA Bionics, Inc. | 4 | $89 |
| Esperion Therapeutics, Inc. | 5 | $78 |
| Sanofi-aventis U.S. LLC | 4 | $69 |
| Cequr Corporation | 2 | $67 |
| Boehringer Ingelheim | 4 | $66 |
| Tandem Diabetes Care, Inc. | 4 | $66 |
| Mannkind Corporation | 3 | $63 |
| Antares Pharma, Inc. | 4 | $60 |
| Amneal Pharmaceuticals LLC | 2 | $39 |
| Recordati_rare_diseases_inc. | 2 | $35 |
| Averitas Pharma Inc. | 1 | $29 |
| Phathom Pharmaceuticals, Inc. | 1 | $28 |
| IBSA Pharma Inc. | 1 | $14 |
| Avvisto Therapeutics, LLC | 1 | $14 |
| Halozyme Inc | 1 | $13 |
| Lifescan, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MINIMED 780G$281
- Repatha$251
- DEXCOM G7 GSS (161)$157
- Korlym$107
How this compares
$5,661 in reported general payments places this provider in the 90th percentile of 230 gerontology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 294 | $331,015 |
| MounjaroTirzepatide | 147 | $170,762 |
| JardianceEmpagliflozin | 153 | $106,572 |
| RybelsusSemaglutide | 59 | $81,055 |
| TrulicityDulaglutide | 56 | $67,514 |
| FarxigaDapagliflozin Propanediol | 78 | $58,338 |
| Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt | 31 | $40,870 |
| TradjentaLinagliptin | 51 | $30,257 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 38 | $28,772 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 26 | $23,578 |
| KerendiaFinerenone | 25 | $23,511 |
| Tresiba Flextouch U-200Insulin Degludec | 23 | $21,790 |
| Xultophy 100-3.6Insulin Degludec/Liraglutide | 13 | $17,549 |
| Tresiba Flextouch U-100Insulin Degludec | 24 | $11,551 |
| HumalogInsulin Lispro | 40 | $9,577 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus, Xultophy 100-3.6 | $277 | $429,620366 claims |
| Lilly USA, LLCMounjaro, Trulicity, Humalog, Insulin Lispro | $696 | $249,634266 claims |
| Boehringer IngelheimJardiance, Tradjenta | $66 | $136,828204 claims |
| AstraZenecaFarxiga | $262 | $58,33878 claims |
| BayerKerendia | $230 | $23,51125 claims |
| AbbVieSynthroid | $118 | $2,97039 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $39 | $72767 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 230 gerontology providers in Indiana.
Other gerontology in Terre Haute
- Rhonda WestTerre Haute$2K
- Angela PattiMunster$44K
- Jessica KiszkaMunster$42K
- Sandra GarofaloIndianapolis$24K
- Megan MonnierBloomington$23K
- Diane BrackinFishers$13K
- Karie BeasleyEvansville$13K
- Mary ParkerFort Wayne$13K
- Morgan SlawsonMunster$9K
- Marena ArnoldFort Wayne$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.